Updates on capivasertib, belzutifan, talquetamab, & durvalumab
Jun 18, 2026 - 00:19:32
Radio and PodcastLive Radio & PodcastsScience & Medicine
Promising Pancreatic Cancer Data
This week we highlight some promising clinical research in the pancreatic cancer space. Daraxonrasib has shown OS benefit vs. chemo in the 2nd-line setting of metastatic pancreatic cancer compared to investigator's choic...
About This Episode
Promising Pancreatic Cancer Data is an episode from OncoPharm by OncoPharmPod. This week we highlight some promising clinical research in the pancreatic cancer space. Daraxonrasib has shown OS benefit vs. chemo in the 2nd-line setting of me...
Podcast
This episode belongs to OncoPharm.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 23, 2026, 00:13:56 long, audio available.
Related Episodes
Continue listening to more episodes from OncoPharm.
Asco '26
Jun 11, 2026 - 00:25:38
Pivekimab sunirine
May 28, 2026 - 00:13:49
BCL2 & HER2 Targeting Agent Updates
May 21, 2026 - 00:13:45
IMHOTEP, PJP, and more
May 14, 2026 - 00:09:59
Vepdegestrant
May 7, 2026 - 00:11:35
Targets Trop 2
Apr 30, 2026 - 00:12:41
ICI-Induced T1DM
Apr 16, 2026 - 00:13:24